Skip to content
Boston Collaborative Drug Surveillance Program (BCDSP)
  • Home
  • Services
  • Research
  • Our Team
  • History
  • Publications

Myriam Cordey

  • Home
  • Myriam Cordey

Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink

Posted by By BCDSP November 30, 2022Posted inCPRD, Drug Safety Studies, Safety of other important drugs
Journal: Drug Safety Authors: Rebecca Persson, Myriam Cordey, Maria Paris, Susan Jick NLM Citation: Persson R, Cordey M, Paris M, Jick S. Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings…
Read More
  • @BCDSP_DRG on Twitter
Boston Collaborative Drug Surveillance Program

11 Muzzey Street | Lexington, MA 02421 USA
Phone: +1 (781) 862-6660
Fax: +1 (781) 862-1680
E-mail: bcdsp@bcdsp.org

Copyright 2025 — Boston Collaborative Drug Surveillance Program (BCDSP). All rights reserved.
Scroll to Top